|
|||||
|
|
The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update |
|
| Authors: | J. M. Lusher, D. A. Roth&dagger |
| Affiliation: | Hemophilia, Hemostasis-Thrombosis Center, Children's Hospital of Michigan, Detroit, MI;;and Clinical Research and Development, Wyeth Research, Cambridge, MA, USA |
| Abstract: | |
| Keywords: | |